Cleared Traditional

K954045 - AXSYM RUBELLA IGG ANTIBODY ASSAY (FDA 510(k) Clearance)

Sep 1996
Decision
392d
Days
Class 2
Risk

K954045 is an FDA 510(k) clearance for the AXSYM RUBELLA IGG ANTIBODY ASSAY. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II - Special Controls, product code LFX).

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on September 24, 1996, 392 days after receiving the submission on August 29, 1995.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3510.

Submission Details

510(k) Number K954045 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 1995
Decision Date September 24, 1996
Days to Decision 392 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LFX — Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3510